The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells

Oncogene

Volumn 16, Issue 3, 1998, Pages 349-357

  Steegenga, Wilma T ^a   Riteco, Nicole ^a   Jochemsen, A G ^b   Fallaux, Frits J ^a   Bos, Johannes L ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenovirus; E1A; E4orf6; Large E1B; p53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR CELL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS MUTANT;

ADENOVIRIDAE;

EID: 0032556920     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201540     Document Type: Article

References (53)

1. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F. (1996). Science, 274, 373-376.
2. Crook T and Vousden KH. (1992). EMBO J., 11, 3935-3940.
3. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B et al. (1990). Mol. Cell Biol., 10, 5772-5781.
4. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nat. Genet., 4, 42-46.
5. Dobner T, Horikoshi N, Rubenwolf S and Shenk T. (1996). Science, 272, 1470-1473.
6. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC and Van Der Eb AJ. (1996). Hum. Gene Ther., 7, 215-222.
7. Gottlieb TM and Oren M. (1996). Biochim. Biophys. Acta., 1287, 77-102.
8. Graham FL and Prevec L. (1991). Gene transfer and expression protocols. The humana press, Clifton, NJ.
9. Grand RJ, Grant ME and Gallimore PH. (1994). Virology, 203, 229-240.
10. Grand RJ, Lecane PS, Owen D, Grant ME, Roberts S, Levine AJ and Gallimore PH. (1995). Virology, 210, 323-334.
11. Grand RJ, Lecane PS, Roberts S, Grant ME, Lane DP, Young ES, Dawson CW and Gallimore PH. (1993). Virology, 193, 579-591.
12. Grand RJ, Owen D, Rookes SM & Gallimore PH. (1996). Virology, 218, 23-34.
13. Halbert DN, Cutt JR and Shenk T. (1985). J. Virol., 56, 250-257.
14. Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R and Shenk T. (1995). Mol. Cell. Biol., 15, 227-234.
15. Huibregtse JM, Scheffner M & Howley PM. (1993a). Mol. Cell. Biol., 13, 775-784.
16. Huibregtse JM, Scheffner M & Howley PM. (1993b). Mol. Cell. Biol., 13, 4918-4927.
17. Jochemsen AG, Peltenburg ET, te Pas MF, de Wit CM, Bos JL and van der Eb AJ. (1987). EMBO J., 6, 3399-405.
18. Kao CC, Yew PR and Berk AJ. (1990). Virology, 179, 806-814.
19. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
20. Kolls J, Peppel K, Silva M and Beutler B. (1994). Proc. Natl Acad. Sci. USA, 91, 215-219.
21. Kubbutat MH and Vousden KH. (1997). Mol. Cell. Biol., 17, 460-468.
22. Linzer DI and Levine AJ. (1979). Cell, 17, 43-52.
23. Lowe SW and Ruley HE. (1993). Genes Dev., 7, 535-545.
24. Mak I, Mak S and Benchimol S. (1988). Virology, 163, 201-204.
25. Maki CG and Howley PM. (1997). Mol. Cell. Biol., 17, 355-363.
26. Marcellus RC, Teodoro JG, Wu T, Brough DE, Ketner G, Shore GC and Branton PE. (1996). J. Virol., 70, 6207-6215.
27. Moore M, Horikoshi N and Shenk T. (1996). Proc. Natl Acad. Sci. USA, 93, 11295-11301.
28. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
29. Nevels M, Rubenwolf S, Spruss T, Wolf H and Dobner T. (1997). Proc. Natl Acad. Sci. USA, 94, 1206-1211.
30. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, et al. (1989). Nature, 342, 705-708.
31. Oren M, Maltzman W and Levine AJ. (1981). Mol. Cell. Biol., 1, 101-110.
32. Ornelles DA and Shenk T. (1991). J. Virol., 65, 424-429.
33. Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J and Ozturk M. (1993). FASEB J., 7, 1407-1413.
34. Reich NC, Sarnow P, Duprey E and Levine AJ. (1983). Virology 128, 480-484.
35. Rubenwolf S, Schutt H, Nevels M, Wolf H and Dobner T. (1997). J. Virol., 71, 1115-1123.
36. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
37. Scheffner M, Munger K, Byrne JC and Howley PM. (1991). Proc. Natl Acad. Sci. USA, 88, 5523-5527.
38. Scheffner M, Takahashi T, Huibregtse JM, Minna JD and Howley PM. (1992). J. Virol., 66, 5100-5105.
39. Scheffner M, Werness BA, Huihregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
40. Steegenga WT, Shvarts A, van Laar T, van der Eb AJ and Jochemsen AG. (1995a). Oncogene, 11, 49-57.
41. Steegenga WT, van Laar T, Riteco N, Mandarino A, Shvarts A, van der Eb AJ and Jochemsen AG. (1996). Mol. Cell. Biol., 16, 2101-2109.
42. Steegenga WT, van Laar T, Shvarts A, Terleth C, van der Eb AJ and Jochemsen AG. (1995b). Virology, 212, 543-554.
43. Stratford-Perricaudet LD and Perricaudet M. (1991). Human Gene Transfer, Paris, Inserm John Libbey Euro-text.
44. Van den Heuvel SJ, van Laar T, Kast WM, Melief CJ, Zantema A and van der Eb AJ. (1990). EMBO J., 9, 2621-2629.
45. Van den Heuvel SJ, van Laar T, The I and van der Eb AJ. (1993). J. Virol., 67, 5226-5234.
46. Vojtesek B and Lane DP. (1993). J. Cell. Sci., 105, 607-612.
47. Weinberg DH and Ketner G. (1983). Proc. Natl Acad. Sci. USA, 80, 5383-5386.
48. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG and Stanbridge EJ. (1987). Science, 236, 175-180.
49. Yew PR and Berk AJ. (1992). Nature, 357, 82-85.
50. Yew PR, Kao CC and Berk AJ. (1990). Virology, 179, 795-805.
51. Yew PR, Liu X and Berk AJ. (1994). Genes Dev., 8, 190-202.
52. Zambetti GP and Levine AJ. (1993). FASEB J., 7, 855-865.
53. Zantema A, Schrier PI, Davis-Olivier A, van Laar T, Vaessen RT and van der EA. (1985). Mol. Cell. Biol., 5, 3084-3091.